NDC properties for NDC 9 0074-0124
NDC item 00074012401
NDC 9 | 0074-0124 |
---|---|
NDC 10 | 0074-0124-01 |
NDC Item | 00074012401 |
packaging | 1 KIT in 1 CARTON (0074-0124-01) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA125057 |
FDA SPL set id | 770190 |
Labeler | AbbVie Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2017-04-21 |
Marketing status | ACTIVE |
NDC item 00074012402
NDC 9 | 0074-0124 |
---|---|
NDC 10 | 0074-0124-02 |
NDC Item | 00074012402 |
packaging | 2 KIT in 1 CARTON (0074-0124-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA125057 |
FDA SPL set id | 770190 |
Labeler | AbbVie Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2017-04-21 |
Marketing status | ACTIVE |
NDC item 00074012474
NDC 9 | 0074-0124 |
---|---|
NDC 10 | 0074-0124-74 |
NDC Item | 00074012474 |
packaging | 1 KIT in 1 CARTON (0074-0124-74) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET |
BLA | BLA125057 |
FDA SPL set id | 770190 |
Labeler | AbbVie Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2017-04-21 |
Marketing status | ACTIVE |
NDC item 83457012301
NDC 9 | 83457-123 |
---|---|
NDC 10 | 83457-123-01 |
NDC Item | 83457012301 |
packaging | 0.8 mL in 1 SYRINGE |
packaging | 1 in 1 TRAY |
FDA SPL set id | 771346 |
Labeler | Cordavis Limited |
Label type | HUMAN PRESCRIPTION DRUG LABEL |
NDC item 83457012402
NDC 9 | 83457-124 |
---|---|
NDC 10 | 83457-124-02 |
NDC Item | 83457012402 |
packaging | 2 KIT in 1 CARTON (83457-124-02) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (83457-123-01) / .8 mL in 1 SYRINGE * 1 mL in 1 PACKET (83457-927-01) |
BLA | BLA125057 |
FDA SPL set id | 771346 |
Labeler | Cordavis Limited |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | BLA |
Marketing effective time low | 2024-02-14 |
Marketing status | ACTIVE |